Labshake search
Citations for Invivogen :
301 - 350 of 579 citations for 5 M TOLYL FURAN 2 CARBALDEHYDE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... 5 μg gp120 was adjuvanted with 10 μg monophosphoryl lipid A (InvivoGen, vac-mpla) and 10 μg saponin (InvivoGen ...
-
bioRxiv - Immunology 2023Quote: ... and mixed with adjuvant system 04 (AS04: 5 μg MPLA-SM (InvivoGen, tlrl-mpla2) and alhydrogel adjuvant 2% (alum ...
-
bioRxiv - Genetics 2021Quote: ... 2 µg of polyinosinic-polycytidylic acid (poly(I:C) LMW) (InvivoGen, tlrl-picw) were transfected ...
-
bioRxiv - Cell Biology 2022Quote: ... 2 µg of poly(I:C) was mixed with 20 µl LyoVec (Invivogen), incubated for 15 min ...
-
bioRxiv - Microbiology 2021Quote: ... and the transduced cells were selected with 2 μg/ml puromycin (InvivoGen) in growth medium for 5 days at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... and the transduced cells were selected with 2 μg/ml puromycin (InvivoGen) and 8 μg/ml blasticidin (InvivoGen ...
-
bioRxiv - Microbiology 2021Quote: ... and the transduced cells were selected with 2 μg/ml puromycin (InvivoGen) in growth medium for 5 days at 37°C ...
-
bioRxiv - Cell Biology 2022Quote: ... Transgene induction was initiated with the addition of 2 μM doxycycline (InvivoGen) 2 hours prior to siRNA addition ...
-
bioRxiv - Molecular Biology 2020Quote: ... positive integration events were selected for with puromycin (2 μg/mL, InvivoGen). Single colonies were picked into fibronectin-coated (10 μg/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... for 10 days or 2 μg/mL puromycin (InvivoGen; #ant-pr-1) for 4 days to generate stable cell lines.
-
bioRxiv - Immunology 2021Quote: ... 2% AdjuPhos® (aluminium phosphate refered as Alum) were purchased from Invivogen.
-
bioRxiv - Molecular Biology 2021Quote: ... the culture medium was supplemented with 2 µg/mL of puromycin (InvivoGen) and 10 µg/mL of blasticidin (InvivoGen).
-
bioRxiv - Immunology 2020Quote: ... or transfected with 2 μg/ml of G3-YSD (InvivoGen, tlrl-ydna), 2 μg/ml of C3-YSD (InvivoGen ...
-
bioRxiv - Microbiology 2022Quote: ... All vaccines were formulated with Aldydrogel® 2% aluminum hydroxide gel (InvivoGen) at a 1:9 ratio (50 μL vaccine to 5.5 μL adjuvant in 44.5 μL sterile PBS) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.2 µg/g was used for all experiments (InvivoGen, tlrl-nacairs-2). Anti-PD1 (InvivoGen ...
-
bioRxiv - Biochemistry 2022Quote: ... cells were selected with 2 μg/mL puromycin (Invivogen: ant-pr-1).
-
bioRxiv - Immunology 2023Quote: ... Cells were transfected with 2 µg/ml poly(I:C) (Invivogen, tlrl-pic) or 2 µg/ml poly(dA:dT ...
-
bioRxiv - Physiology 2023Quote: ... and 1% normocin antibiotic (ant-nr-2, Invivogen, San Diego, CA, USA) at 20% oxygen (5% CO2 ...
-
bioRxiv - Cell Biology 2023Quote: ... Transgene induction was initiated with the addition of 2 µM doxycycline (InvivoGen) 3 h prior to siRNA addition ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... Puromycin selection was performed using 2 μg/mL puromycin (InvivoGen, Toulouse, France) to the culture medium 48 hours post transduction ...
-
bioRxiv - Cell Biology 2023Quote: ... 4 µM digitonin) with or without 7 µM 2’,3’-cGAMP (Invivogen). Cells were further washed in PBS and incubated in culture medium until collection ...
-
bioRxiv - Immunology 2023Quote: ... adjuvanted with 100 μg/dose alhydrogel adjuvant 2% (InvivoGen, #vac-alu-250) and 20 μg/dose CpG ODN 2395 – TLR9 ligand (InvivoGen ...
-
bioRxiv - Immunology 2023Quote: ... All vaccines were formulated with Aldydrogel® 2% aluminum hydroxide gel (InvivoGen) at a 1:9 ratio (50 μL vaccine to 5.5 μL adjuvant in 44.5 μL sterile PBS) ...
-
bioRxiv - Immunology 2023Quote: ... LPS-primed mouse BMDMs were transfected with 2 μg poly(dA:dT) (InvivoGen) using Lipofectamine 3000 and incubated for 6 h.
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with antibiotic Primocin (100 µg/mL, Invivogen; Catalogue #ant-pm-2), and 2mM L-Glutamine (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2023Quote: ... 5μM Y-27632 (Selleckbio #S1049) and Primocin 500x (Invivogen #ant-pm-2). To initiate air–liquid interface (ALI ...
-
bioRxiv - Systems Biology 2024Quote: ... Cells were then stimulated with 4µg/ml of cGAMP(pS)2 (Invivogen) for 6 hours ...
-
bioRxiv - Molecular Biology 2023Quote: ... the selection lasted for 2 weeks with blasticidin at 10µg/mL (Invivogen). For NoDiceΔPKR FHA:CTRL or DICER WT ...
-
bioRxiv - Molecular Biology 2023Quote: ... the selection lasted for 2 weeks with blasticidin at 15µg/mL (Invivogen). For NoDiceΔPKR ...
-
bioRxiv - Immunology 2022Quote: ... Cells were stimulated with 2.5 µg/ml of R848 (Invivogen, catalog no. tlrl-r848-5) in complete medium (RPMI 1640 medium (catalog no ...
-
bioRxiv - Biochemistry 2023Quote: ... followed by selection via addition of 5 μg/mL puromycin (cat# ant-pr-1, InvivoGen) over 10 days ...
-
bioRxiv - Immunology 2023Quote: ... The Class C CpG ODN_2395 sequence (5’-TCGTCGTTTTCGGCGCGCGCCG-3’) was obtained from Invivogen (#tlrl-2395). We used the crystal structure of mouse TLR9 extracellular domain (TLR9 ECD ...
-
bioRxiv - Cancer Biology 2022Quote: ... Dnmt3a+/fl:Mx1-Cre mice received five intraperitoneal injections of poly(I:C) (InvivoGen, #tlrl-pic-5). Mx1-Cre-driven recombination was validated by PCR using genomic DNA from peripheral blood mononuclear cells ...
-
bioRxiv - Immunology 2023Quote: ... cells were transfected with a RIG-I agonist (5’ triphosphate hairpin RNA, 3p-hpRNA, Invivogen). Cells were analyzed for antigen expression or luciferase/NLuc expression ...
-
bioRxiv - Genetics 2019Quote: ... and the cultures were supplemented with 2 μg/ml puromycin (InvivoGen, ant-pr) and incubating for 48 hours ...
-
bioRxiv - Genetics 2019Quote: ... and the cultures were supplemented with 2 μg/ml puromycin (InvivoGen, ant-pr) and incubated at 37 °C and 5% CO2.
-
bioRxiv - Biochemistry 2021Quote: ... and maintained in M199 with 0.1mg/mL Primocin (InvivoGen, Cat#ant-pm-2) until further experimentation ...
-
bioRxiv - Cancer Biology 2022Quote: ... The STING agonist 2’3’-cGAM(PS)2(Rp/Sp) (Invivogen, cat. tlrl-nacga2srs) and IRF3 inhibitor MRT67307 (Invivogen ...
-
bioRxiv - Genetics 2019Quote: ... For stable sgRNA and shRNA expression 3 days puromycin (2 μg/ml, Invivogen) selection was applied.
-
bioRxiv - Molecular Biology 2021Quote: ... cells were either left untreated or treated with puromycin (2 μg/ml; Invivogen). At 10d after plating ...
-
bioRxiv - Immunology 2020Quote: ... plus the TLR-7 and TLR-8 agonist Resiquimod (R848, 2 µM, InvivoGen), for 24 h ...
-
bioRxiv - Molecular Biology 2023Quote: ... HS solid medium containing 1.4% agar and 2 μg/mL puromycin (InvivoGen, Inc.) was used for screening M ...
-
Functional characterization of ATP13A2 variants associated with distinct neurodegenerative disordersbioRxiv - Molecular Biology 2023Quote: ... and selection antibiotic (160 μg/mL hygromycin or 2 μg/mL puromycin (Invivogen)) ...
-
bioRxiv - Bioengineering 2023Quote: ... CpG1826 (Vac-1826) and Alum (Alhydrogel 2%, vac-alu) were purchased from Invivogen. Maxisorp plates were purchased from Thermofisher ...
-
bioRxiv - Microbiology 2023Quote: ... Omicron BA.1 and Omicron BA.2 were purchased from InvivoGen (Toulouse, France). SARS-CoV-2pp were generated as previously described ...
-
bioRxiv - Cancer Biology 2024Quote: ... A positive control of 2 µg/ml of Puromycin (InVivoGen, ant-pr-1) was included ...
-
Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistancebioRxiv - Cancer Biology 2024Quote: ... Infected cells were selected using puromycin for 3 days (2 µg/ml, InvivoGen) or hygromycin B for 7 days (500 µg/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... followed by stimulation with 20.7 μM nigericin (Invivogen tlrl-nig; stock 5 mg/ml in ethanol) for 2 hours and 15 minutes ...
-
bioRxiv - Immunology 2021Quote: ... ABCs were induced in the presence of R848 (500 ng/ml, Invivogen, Cat#tlrl-r848-5), anti-CD40 (1 ug/ml ...
-
bioRxiv - Cancer Biology 2021Quote: ... Melanocytes were further isolated by 5-day exposure to 10µg/mL G418 (InvivoGen, ant-gn-1). BRAF status was confirmed via sanger sequencing (Quintarabio ...